ICL Good Will vs Net Receivables Analysis
ICL Stock | USD 4.63 0.07 1.54% |
ICL Israel financial indicator trend analysis is infinitely more than just investigating ICL Israel Chemicals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICL Israel Chemicals is a good investment. Please check the relationship between ICL Israel Good Will and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Good Will vs Net Receivables
Good Will vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICL Israel Chemicals Good Will account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.
The correlation between ICL Israel's Good Will and Net Receivables is 0.87. Overlapping area represents the amount of variation of Good Will that can explain the historical movement of Net Receivables in the same time period over historical financial statements of ICL Israel Chemicals, assuming nothing else is changed. The correlation between historical values of ICL Israel's Good Will and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Good Will of ICL Israel Chemicals are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Good Will i.e., ICL Israel's Good Will and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.87 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Net Receivables
Most indicators from ICL Israel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Sales General And Administrative To Revenue is expected to rise to 0.08 this year, although the value of Selling General Administrative will most likely fall to about 379.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 216M | 327M | 176.7M | 120.4M | Depreciation And Amortization | 588M | 713M | 590.1M | 371.6M |
ICL Israel fundamental ratios Correlations
Click cells to compare fundamentals
ICL Israel Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ICL Israel fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.2B | 9.7B | 11.1B | 11.8B | 11.5B | 7.7B | |
Short Long Term Debt Total | 2.6B | 2.8B | 3.0B | 2.8B | 2.7B | 2.2B | |
Other Current Liab | 587M | 741M | 938M | 1.0B | 844.0M | 531.1M | |
Total Current Liabilities | 1.8B | 2.2B | 2.6B | 2.6B | 2.6B | 1.9B | |
Total Stockholder Equity | 3.9B | 3.9B | 4.5B | 5.5B | 5.7B | 3.1B | |
Property Plant And Equipment Net | 5.2B | 5.6B | 5.8B | 6.0B | 6.3B | 3.7B | |
Net Debt | 2.5B | 2.6B | 2.5B | 2.4B | 2.2B | 2.0B | |
Retained Earnings | 3.9B | 3.8B | 4.3B | 5.4B | 5.5B | 5.8B | |
Accounts Payable | 712M | 735M | 1.1B | 1.0B | 904.5M | 633.2M | |
Cash | 95M | 214M | 473M | 417M | 416.5M | 437.4M | |
Non Current Assets Total | 6.5B | 6.8B | 7.2B | 7.2B | 7.5B | 4.8B | |
Non Currrent Assets Other | 353M | 393M | 279.8M | 228M | 217.9M | 228.4M | |
Cash And Short Term Investments | 191M | 314M | 564M | 508M | 587.1M | 325.4M | |
Net Receivables | 1.2B | 1.3B | 1.8B | 1.9B | 1.6B | 1.2B | |
Good Will | 302M | 320M | 502M | 507M | 525.6M | 266.1M | |
Common Stock Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.4B | |
Short Term Investments | 92M | 96M | 100M | 91M | 170.6M | 127.4M | |
Liabilities And Stockholders Equity | 9.2B | 9.7B | 11.1B | 11.8B | 11.5B | 7.7B | |
Non Current Liabilities Total | 3.4B | 3.4B | 3.7B | 3.4B | 2.9B | 2.6B | |
Inventory | 1.3B | 1.3B | 1.6B | 2.1B | 1.7B | 1.3B | |
Other Current Assets | 51M | 50M | 115.2M | 4.0B | 121.0M | 114.9M | |
Other Stockholder Equity | (62M) | (56M) | (36M) | (27M) | (25.8M) | (24.5M) | |
Total Liab | 5.1B | 5.6B | 6.3B | 6.0B | 5.5B | 4.5B | |
Property Plant And Equipment Gross | 5.3B | 5.6B | 12.5B | 13.0B | 13.8B | 14.5B | |
Total Current Assets | 2.7B | 2.8B | 3.9B | 4.5B | 4.0B | 2.9B | |
Accumulated Other Comprehensive Income | (439M) | (312M) | (306M) | (443M) | (335.2M) | (352.0M) | |
Short Term Debt | 420M | 684M | 577M | 512M | 850.9M | 537.1M | |
Current Deferred Revenue | 42M | 17M | 33M | 41M | 16.9M | 16.0M | |
Intangible Assets | 332M | 336M | 365M | 345M | 343M | 403.7M | |
Other Liab | 1.2B | 1.3B | 1.3B | 1.1B | 1.3B | 1.1B | |
Other Assets | 362M | 309M | 378M | 524M | 434.7M | 384.2M | |
Long Term Debt | 2.2B | 2.1B | 2.4B | 2.3B | 1.6B | 2.3B | |
Property Plant Equipment | 5.3B | 5.6B | 5.8B | 6.0B | 6.9B | 5.1B | |
Net Tangible Assets | 3.3B | 3.3B | 3.7B | 4.6B | 5.3B | 3.1B | |
Long Term Investments | 140M | 83M | 26M | 3M | 2M | 1.9M | |
Short Long Term Debt | 371M | 684M | 577M | 512M | 786M | 523.7M | |
Long Term Debt Total | 1.8B | 2.2B | 2.1B | 2.4B | 2.2B | 1.9B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ICL Israel in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ICL Israel's short interest history, or implied volatility extrapolated from ICL Israel options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for ICL Stock analysis
When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Dividend Share 0.277 | Earnings Share 0.5 | Revenue Per Share 5.845 | Quarterly Revenue Growth (0.19) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.